Risk Factors & Outcomes for Clinically Documented Infections in Pediatric Cancer Patients With Fever & Neutropenia

Launched by ASSIUT UNIVERSITY · Aug 28, 2015

Keywords

ClinConnect Summary

This clinical trial is looking at children with cancer who have a fever and low white blood cell counts, a condition known as febrile neutropenia. The goal is to find out which clinical signs and lab test results can help doctors predict if these children are at risk for developing serious infections or complications. By understanding these risk factors, healthcare providers can better manage the care of young patients during this challenging time.

To be eligible for the study, participants must be under 19 years old and have been diagnosed with either blood cancers or solid tumors. They also need to be admitted to the pediatric oncology department for at least 24 hours after experiencing fever and neutropenia. The trial is currently recruiting participants, and it’s open to all genders. Those who join the study can expect to undergo a thorough evaluation, and their data will help improve how doctors care for children with similar conditions in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients whose age less than 19 years.
• • Patients diagnosed with hematologic malignancies or solid tumors.
• • Patients admitted at the pediatric oncology department for at least 24-hour period after documentation of an episode of fever \& neutropenia at the time of initial evaluation at the pediatric oncology clinic.
• • Patients who previously have been admitted at the pediatric oncology department, after documentation of an episode of fever \& neutropenia.
• Exclusion Criteria:
• • Patients whose age is more than 18 years.
• • Patients not fulfilling the criteria for diagnosis of fever and neutropenia.